Michael Michail
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael Michail has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Adam J. Brown
Victorian Heart Institute and Victorian Heart Hospital, Monash Health, Monash University, 631 Blackburn Road, Clayton, VIC 3168, Australia
8 shared publications - James Donald Cameron
Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia
7 shared publications Nitesh Nerlekar
Victorian Heart Institute and Victorian Heart Hospital, Monash University, Monash Health, 631 Blackburn Road, Clayton, Victoria, 3168, Australia
5 shared publications- Andrea Comella
Victorian Heart Institute and Victorian Heart Hospital, Monash University, Monash Health, 631 Blackburn Road, Clayton, Victoria, 3168, Australia
4 shared publications Anthony Mathur
Institute of Cardiovascular Science, University College London, United Kingdom (M.M., A.M., A.D.H.).
4 shared publicationsJames Cockburn
Sussex Cardiac Centre, Royal Sussex County Hospital, University Hospitals Sussex NHS Foundation Trust, Eastern Road, Brighton, BN2 5BE, UK
4 shared publications
Latest Publications
- 19 June 2025
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (4) , 416-422
Validation of physiological principles of Non-Invasive fractional flow reserve derived from CT coronary angiography
- 19 June 2025
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (4) , 416-422
Validation of physiological principles of Non-Invasive fractional flow reserve derived from CT coronary angiography
- 8 March 2025
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (2) , 247-255
Membranous septum area and the risk of conduction abnormalities following transcatheter aortic valve implantation
- 8 March 2025
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (2) , 247-255
Membranous septum area and the risk of conduction abnormalities following transcatheter aortic valve implantation
- 13 November 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (2) , 267-268
Assessing the feasibility and accuracy of an on-site prototype workstation in assessing CT derived fractional flow reserve in severe aortic stenosis
- 13 November 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 19 (2) , 267-268
Assessing the feasibility and accuracy of an on-site prototype workstation in assessing CT derived fractional flow reserve in severe aortic stenosis
- Open Access
- 17 July 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 18 (6) , 543-550
Computed tomography coronary angiography assessment of left main coronary artery stenosis severity
- 17 July 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 18 (6) , 543-550
Open AccessComputed tomography coronary angiography assessment of left main coronary artery stenosis severity
- 25 April 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 18 (4) , 416-417
Exploring the relationship between pericoronary inflammation and microvascular function
- 25 April 2024
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 18 (4) , 416-417
Exploring the relationship between pericoronary inflammation and microvascular function
- 30 May 2023
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 35 (7) , E355-E364
Novel Adaptations in Percutaneous Right Transaxillary Access for Transcatheter Aortic Valve Implantation Using the Sapien Ultra Valve
The authors describe adaptations for successful right transaxillary access for implantation of a transcatheter heart valve using the Edwards Sapien 3 system.
- 30 May 2023
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 35 (7) , E355-E364
Novel Adaptations in Percutaneous Right Transaxillary Access for Transcatheter Aortic Valve Implantation Using the Sapien Ultra Valve
The authors describe adaptations for successful right transaxillary access for implantation of a transcatheter heart valve using the Edwards Sapien 3 system.
- 9 December 2022
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 35 (1) , E37-E45
Transcatheter Aortic Valve Implantation in Patients With Right Bundle-Branch Block: Should Prophylactic Pacing Be Undertaken?
The authors assess mortality, hospital stay length, and cost in patients with right bundle-branch block undergoing TAVI with or without prophylactic pacing.
- 9 December 2022
- Published by HMP Communications, LLC in Journal of Invasive Cardiology
- Vol. 35 (1) , E37-E45
Transcatheter Aortic Valve Implantation in Patients With Right Bundle-Branch Block: Should Prophylactic Pacing Be Undertaken?
The authors assess mortality, hospital stay length, and cost in patients with right bundle-branch block undergoing TAVI with or without prophylactic pacing.
- 2 November 2022
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 100 (7) , 1302-1306
Feasibility of transcaval access TAVI in morbidly obese patients: A single‐center experience
Objectives: We report a single‐center experience in utilizing the transcaval‐access transcatheter aortic valve implantation (TAVI) as an alternative approach in morbidly obese patients.Background: Morbidly obese patients present frequently for TAVI. Transfemoral arterial access TAVI in these patients is technically challenging due to deep arterial access, resulting in a higher risk of vascular complications. Transcaval access TAVI is increasingly used in patients with prohibitive iliofemoral arterial access.Methods: We used the transcaval approach for eight morbidly obese patients who had otherwise technically feasible femoral arterial access. This technique provides an alternative arterial access point that potentially circumvents some of the challenges relating to femoral arterial access.Results: We report eight morbidly obese patients with a mean body mass index of 42.3 ± 6.2 kg/m2 who underwent transcaval access TAVI at our center (mean EuroScore II 2.47 ± 1.83%). The patient mean age was 70.3 ± 9.8 years; six were female. All eight patients underwent a successful and uncomplicated procedure. The median time to discharge was 2 days and all patients were alive at 30 days.Conclusions: Transcaval access TAVI is a feasible alternative for morbidly obese patients and may reduce vascular complications. Further data are required to evaluate the safety of this approach.
- 2 November 2022
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 100 (7) , 1302-1306
Feasibility of transcaval access TAVI in morbidly obese patients: A single‐center experience
Objectives: We report a single‐center experience in utilizing the transcaval‐access transcatheter aortic valve implantation (TAVI) as an alternative approach in morbidly obese patients.Background: Morbidly obese patients present frequently for TAVI. Transfemoral arterial access TAVI in these patients is technically challenging due to deep arterial access, resulting in a higher risk of vascular complications. Transcaval access TAVI is increasingly used in patients with prohibitive iliofemoral arterial access.Methods: We used the transcaval approach for eight morbidly obese patients who had otherwise technically feasible femoral arterial access. This technique provides an alternative arterial access point that potentially circumvents some of the challenges relating to femoral arterial access.Results: We report eight morbidly obese patients with a mean body mass index of 42.3 ± 6.2 kg/m2 who underwent transcaval access TAVI at our center (mean EuroScore II 2.47 ± 1.83%). The patient mean age was 70.3 ± 9.8 years; six were female. All eight patients underwent a successful and uncomplicated procedure. The median time to discharge was 2 days and all patients were alive at 30 days.Conclusions: Transcaval access TAVI is a feasible alternative for morbidly obese patients and may reduce vascular complications. Further data are required to evaluate the safety of this approach.
- 1 February 2021
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 14 (3) , 356-359
Discordance Between Hyperemia and Nonhyperemia Pressure Indexes in Patients With Severe Aortic Stenosis
- 1 February 2021
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 14 (3) , 356-359
Discordance Between Hyperemia and Nonhyperemia Pressure Indexes in Patients With Severe Aortic Stenosis